Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2025-08-26 Governance Information
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
董事会议事规则
Governance Information Classification · 100% confidence The document is titled "内蒙古大唐药业股份有限公司董事会议事规则" which translates to "Inner Mongolia Datang Pharmaceutical Co., Ltd. Board Meeting Rules." It details the rules and procedures governing the board of directors' meetings, including the composition, duties, meeting protocols, voting procedures, and responsibilities of board members. It is a governance document outlining internal rules and board structure rather than a report of financial results, audit, or announcements related to shareholder meetings or capital changes. There is no indication of financial data, voting results, or report publication. The content aligns with governance practices and internal company rules for board management. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial and contains detailed governance rules, supporting a high confidence in this classification.
2025-08-26 Chinese
董事会战略委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the 'Work Rules of the Board Strategic Committee' of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the composition, responsibilities, meeting procedures, and governance rules of the Board's Strategic Committee. It is a governance-related document focusing on internal rules and board committee structure rather than financial results, audit, or shareholder voting. There is no indication of financial data, audit information, or shareholder meeting materials. The document is not an announcement of a report but a detailed governance policy. Therefore, it fits best under Governance Information (CGR). The document length is 1823 characters, which is consistent with a detailed governance policy rather than a brief announcement or a full report.
2025-08-26 Chinese
内部审计制度
Audit Report / Information Classification · 95% confidence The document is titled '内蒙古大唐药业股份有限公司内部审计制度' which translates to 'Internal Audit System of Inner Mongolia Datang Pharmaceutical Co., Ltd.' It details the internal audit policies, responsibilities, procedures, and penalties within the company. It includes sections on the audit committee, audit scope, audit rights, and audit work procedures. The document is a formal announcement of the internal audit system approved by the board of directors on August 27, 2025. It is not a standalone audit report, nor is it an annual or interim financial report. It is also not a certification or a brief announcement but a detailed internal governance document related to audit practices. This fits best under 'Audit Report / Information (AR)' which covers standalone audit reports and applied accounting principles, including internal audit systems and procedures. The document length is 3676 characters, which is sufficient for a substantive policy document but not a full annual report. Therefore, the classification is AR with high confidence. FY 2025
2025-08-26 Chinese
董事会提名委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the 'Work Rules of the Board Nomination Committee' of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the composition, responsibilities, procedures, and rules of the board nomination committee. There is no financial data, no mention of financial results, no voting results, no announcements of report publications, or any other regulatory filings. The content is focused on governance structure and internal rules related to board nominations and management appointments. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 2432 characters, which is sufficient for a detailed governance document and not a brief announcement or certification. Therefore, the classification is CGR with high confidence.
2025-08-26 Chinese
第四届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of Inner Mongolia Datang Pharmaceutical Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to other announcements and reports published elsewhere. The content focuses on board decisions, governance changes (such as the cancellation of the supervisory board and amendments to the company charter), and internal management system revisions. It does not contain financial statements or detailed financial performance data. The document is not a full annual or interim report, nor is it a simple announcement of a report publication. It is clearly a Board/Management Information announcement about board meeting resolutions and governance matters.
2025-08-26 Chinese
关于召开2025年第一次临时股东会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for convening the 2025 first extraordinary general meeting (临时股东会) of shareholders of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items for shareholder approval, registration procedures, and proxy authorization forms. It does not contain financial statements or results but is an announcement related to a shareholders' meeting. The document is not a full report, earnings release, or management discussion but a formal meeting notice and proxy solicitation material. Therefore, it fits best under Proxy Solicitation & Information Statement (PSI). The document length is 3580 characters, which is consistent with a detailed meeting notice rather than a full report.
2025-08-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.